134 related articles for article (PubMed ID: 32481814)
41. Zwitterionic carbon dot-encapsulating pH-responsive mesoporous silica nanoparticles for NIR light-triggered photothermal therapy through pH-controllable release.
Ryplida B; Lee G; In I; Park SY
Biomater Sci; 2019 May; 7(6):2600-2610. PubMed ID: 30984942
[TBL] [Abstract][Full Text] [Related]
42. Intracellular acid-triggered drug delivery system using mesoporous silica nanoparticles capped with T-Hg
He D; He X; Wang K; Chen M; Zhao Y; Zou Z
J Mater Chem B; 2013 Mar; 1(11):1552-1560. PubMed ID: 32260718
[TBL] [Abstract][Full Text] [Related]
43. Advances in the stimuli-responsive mesoporous silica nanoparticles as drug delivery system nanotechnology for controlled release and cancer therapy.
Zhu Y; Bai Y; He J; Qiu X
3 Biotech; 2023 Aug; 13(8):274. PubMed ID: 37457870
[TBL] [Abstract][Full Text] [Related]
44. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
[TBL] [Abstract][Full Text] [Related]
45. Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: layer thickness-dependent release profiles and biocompatibility.
Feng W; Zhou X; He C; Qiu K; Nie W; Chen L; Wang H; Mo X; Zhang Y
J Mater Chem B; 2013 Nov; 1(43):5886-5898. PubMed ID: 32261055
[TBL] [Abstract][Full Text] [Related]
46. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and Optimization of Mesoporous Silica Nanoparticles for Ruthenium Polypyridyl Drug Delivery.
Harun SN; Ahmad H; Lim HN; Chia SL; Gill MR
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498795
[TBL] [Abstract][Full Text] [Related]
48. Poly(propylene imine) dendrimer caps on mesoporous silica nanoparticles for redox-responsive release: smaller is better.
Nadrah P; Porta F; Planinšek O; Kros A; Gaberšček M
Phys Chem Chem Phys; 2013 Jul; 15(26):10740-8. PubMed ID: 23689395
[TBL] [Abstract][Full Text] [Related]
49. Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles.
Peretti E; Miletto I; Stella B; Rocco F; Berlier G; Arpicco S
Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30347763
[TBL] [Abstract][Full Text] [Related]
50. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel.
He Y; Liang S; Long M; Xu H
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():12-17. PubMed ID: 28575958
[TBL] [Abstract][Full Text] [Related]
51. Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells.
Zhou S; Wu D; Yin X; Jin X; Zhang X; Zheng S; Wang C; Liu Y
J Exp Clin Cancer Res; 2017 Feb; 36(1):24. PubMed ID: 28166836
[TBL] [Abstract][Full Text] [Related]
52. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
53. Charge-Reversal APTES-Modified Mesoporous Silica Nanoparticles with High Drug Loading and Release Controllability.
Wang Y; Sun Y; Wang J; Yang Y; Li Y; Yuan Y; Liu C
ACS Appl Mater Interfaces; 2016 Jul; 8(27):17166-75. PubMed ID: 27314423
[TBL] [Abstract][Full Text] [Related]
54. ATP-responsive controlled release system using aptamer-functionalized mesoporous silica nanoparticles.
He X; Zhao Y; He D; Wang K; Xu F; Tang J
Langmuir; 2012 Sep; 28(35):12909-15. PubMed ID: 22889263
[TBL] [Abstract][Full Text] [Related]
55. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro.
Li J; Wang H; Yang B; Xu L; Zheng N; Chen H; Li S
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():273-7. PubMed ID: 26478311
[TBL] [Abstract][Full Text] [Related]
56. pH and thermo dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles encapsulated in a copolymer-lipid bilayer.
Wu X; Wang Z; Zhu D; Zong S; Yang L; Zhong Y; Cui Y
ACS Appl Mater Interfaces; 2013 Nov; 5(21):10895-903. PubMed ID: 24127854
[TBL] [Abstract][Full Text] [Related]
57. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
58. Structural and photophysical properties of rare-earth complexes encapsulated into surface modified mesoporous silica nanoparticles.
Malba C; Sudhakaran UP; Borsacchi S; Geppi M; Enrichi F; Natile MM; Armelao L; Finotto T; Marin R; Riello P; Benedetti A
Dalton Trans; 2014 Nov; 43(43):16183-96. PubMed ID: 24874265
[TBL] [Abstract][Full Text] [Related]
59. Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2019 Apr; 45(4):532-547. PubMed ID: 30582382
[TBL] [Abstract][Full Text] [Related]
60. Alizarin Complexone Functionalized Mesoporous Silica Nanoparticles: A Smart System Integrating Glucose-Responsive Double-Drugs Release and Real-Time Monitoring Capabilities.
Zou Z; He D; Cai L; He X; Wang K; Yang X; Li L; Li S; Su X
ACS Appl Mater Interfaces; 2016 Apr; 8(13):8358-66. PubMed ID: 26998551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
